Showing results (171-180 of 344) with videos related to
Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|December 17, 2009
Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapyJong-Mu Sun, Tae Sung Kim, Jeeyun Lee, et al.Nature Communications|February 21, 2020
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicityKwoneel Kim, Hong Sook Kim, Jeong Yeon Kim, et al.Scientific Reports|March 21, 2020
Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic FactorsDong Young Jeong, Kyung Soo Lee, Joon Young Choi, et al.Cancer Research and Treatment|January 22, 2011
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraNae Yu Kim, Jong Mu Sun, Yu-Jung Kim, et al.Translational Lung Cancer Research|January 10, 2022
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatmentSoohyun Hwang, Tae Hee Hong, Sehhoon Park, et al.Clinical Lung Cancer|December 17, 2019
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional TestsSeonggyu Byeon, Boram Lee, Woong-Yang Park, et al.Journal of Medical Internet Research|August 27, 2021
Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot StudyKyungmi Yang, Dongryul Oh, Jae Myoung Noh, et al.European Journal of Cancer (Oxford, England : 1990)|September 27, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancerJoo-Young Byun, Jinyong Kim, Sehhoon Park, et al.Journal of Cancer Research and Clinical Oncology|June 17, 2010
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patientsJong-Mu Sun, Young-Woong Won, Seung Tae Kim, et al.European Journal of Cancer (Oxford, England : 1990)|May 2, 2022
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancerSehhoon Park, Jae Myoung Noh, Yoon-La Choi, et al.Pageof 35